2022
DOI: 10.3390/vaccines10121999
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and Safety of Native and Recombinant Zona Pellucida Immunocontraceptive Vaccines Formulated with Non-Freund’s Adjuvants in Donkeys

Abstract: This study aimed to test zona pellucida (ZP) vaccines’ immunocontraceptive efficacy and safety when formulated with non-Freund’s adjuvant (6% Pet Gel A and 500 Μg Poly(I:C)). Twenty-four jennies were randomly assigned to three treatment groups: reZP (n = 7) received three doses of recombinant ZP vaccine; pZP (n = 9) received two doses of native porcine ZP; and Control group (n = 8) received two injections of placebo. Jennies were monitored weekly via transrectal ultrasonography and blood sampling for serum pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 70 publications
(144 reference statements)
0
1
0
Order By: Relevance
“…An anti-GnRH vaccine applied in horses was associated with a higher incidence lesion, albeit these were also transient in nature [ 51 ]. Various reports have implicated Freund’s adjuvants in vaccine formulations with both native and recombinant ZP antigens in association with injection site reactions in both horses [ 52 ] and donkeys [ 53 , 54 ], and there are currently reported investigations to find alternative adjuvants [ 53 , 55 , 56 ]. Globalization of native pZP vaccines is currently limited by factors including access to the antigen in many countries, animal-derived ZP antigen with associated contamination and biosecurity risks, and the economics of its production [ 36 , 54 , 57 ].…”
Section: Discussionmentioning
confidence: 99%
“…An anti-GnRH vaccine applied in horses was associated with a higher incidence lesion, albeit these were also transient in nature [ 51 ]. Various reports have implicated Freund’s adjuvants in vaccine formulations with both native and recombinant ZP antigens in association with injection site reactions in both horses [ 52 ] and donkeys [ 53 , 54 ], and there are currently reported investigations to find alternative adjuvants [ 53 , 55 , 56 ]. Globalization of native pZP vaccines is currently limited by factors including access to the antigen in many countries, animal-derived ZP antigen with associated contamination and biosecurity risks, and the economics of its production [ 36 , 54 , 57 ].…”
Section: Discussionmentioning
confidence: 99%